litlas
ログインアカウント作成

Carl G. Figdor

1982–2025 年に発表

232
論文数
49,654
被引用数
124
h 指数
229
i10 指数

被引用数

Carl G. Figdor の年別被引用数1969 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 1 件1987 年: 被引用 13 件1988 年: 被引用 14 件1989 年: 被引用 37 件1990 年: 被引用 51 件1991 年: 被引用 74 件1992 年: 被引用 130 件1993 年: 被引用 188 件1994 年: 被引用 201 件1995 年: 被引用 205 件1996 年: 被引用 236 件1997 年: 被引用 234 件1998 年: 被引用 302 件1999 年: 被引用 325 件2000 年: 被引用 314 件2001 年: 被引用 381 件2002 年: 被引用 440 件2003 年: 被引用 448 件2004 年: 被引用 477 件2005 年: 被引用 458 件2006 年: 被引用 458 件2007 年: 被引用 391 件2008 年: 被引用 494 件2009 年: 被引用 436 件2010 年: 被引用 413 件2011 年: 被引用 452 件2012 年: 被引用 487 件2013 年: 被引用 443 件2014 年: 被引用 515 件2015 年: 被引用 356 件2016 年: 被引用 366 件2017 年: 被引用 360 件2018 年: 被引用 412 件2019 年: 被引用 1,234 件2020 年: 被引用 1,262 件2021 年: 被引用 1,265 件2022 年: 被引用 892 件2023 年: 被引用 729 件2024 年: 被引用 1,016 件2025 年: 被引用 471 件2026 年: 被引用 12 件1970〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,995 件、この内訳の 27.7%中国: 引用元論文 1,662 件、この内訳の 9.2%ドイツ: 引用元論文 1,262 件、この内訳の 7%オランダ: 引用元論文 1,202 件、この内訳の 6.7%イギリス: 引用元論文 1,180 件、この内訳の 6.6%フランス: 引用元論文 833 件、この内訳の 4.6%イタリア: 引用元論文 621 件、この内訳の 3.5%日本: 引用元論文 564 件、この内訳の 3.1%カナダ: 引用元論文 471 件、この内訳の 2.6%スペイン: 引用元論文 443 件、この内訳の 2.5%オーストラリア: 引用元論文 430 件、この内訳の 2.4%スイス: 引用元論文 421 件、この内訳の 2.3%
0%27.7%その他 21.8%

機関

分野

  • Immunology and Microbiology34.9%
  • Medicine33.1%
  • Biochemistry, Genetics and Molecular Biology19.9%
  • Engineering3.8%
  • Materials Science2.3%
  • Neuroscience1.7%
  • その他4.3%

トピック

  • Immunotherapy and Immune Responses10.5%
  • Immune Cell Function and Interaction5.6%
  • T-cell and B-cell Immunology4.8%
  • Cancer Immunotherapy and Biomarkers3.5%
  • Cell Adhesion Molecules Research2.9%
  • Immune Response and Inflammation2.8%
  • その他69.9%

共著者

全論文

検索で開く
  1. Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force

    著者: Katarina Wolf, Mariska te Lindert, Marina Krause, Stephanie Alexander, Joost te Riet, Amanda L. Willis, Robert M. Hoffman, Carl G. Figdor, Stephen J. Weiss, Peter Friedl - The Journal of Cell Biology 2013 被引用: 1,379

  2. Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity

    著者: Bettina Weigelin, Annemieke Th. den Boer, Esther Wagena, Kelly Broen, Harry Dolstra, Rob J. de Boer, Carl G. Figdor, Johannes Textor, Peter Friedl - Nature Communications 2021 被引用: 238

  3. PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up

    著者: Maria Camilla Operti, Alexander Bernhardt, Silko Grimm, Andrea Engel, Carl G. Figdor, Oya Tagit - International Journal of Pharmaceutics 2021 被引用: 272

  4. Migrating into the Tumor: a Roadmap for T Cells

    著者: Lieke L. van der Woude, Mark A.J. Gorris, Altuna Halilović, Carl G. Figdor, I. Jolanda M. de Vries - Trends in cancer 2017 被引用: 316

  5. Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses

    著者: Teunis B. H. Geijtenbeek, Ruurd Torensma, Sandra J. van Vliet, Gerard C.F. van Duijnhoven, Gosse J. Adema, Yvette van Kooyk, Carl G. Figdor - Cell 2000 被引用: 1,692

  6. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

    著者: René de Waal Malefyt, J S Abrams, B Bennett, Carl G. Figdor, J E de Vries - The Journal of Experimental Medicine 1991 被引用: 3,812

  7. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells

    著者: Teunis B. H. Geijtenbeek, Douglas S. Kwon, Ruurd Torensma, Sandra J. van Vliet, Gerard C.F. van Duijnhoven, Jeena Middel, Ine L.M.H.A Cornelissen, Hans S.L.M. Nottet, Vineet N. KewalRamani, Dan R. Littman, Carl G. Figdor, Yvette van Kooyk - Cell 2000 被引用: 2,407

  8. Dendritic Cell–Based Immunotherapy: State of the Art and Beyond

    著者: Kalijn F. Bol, Gerty Schreibelt, Winald R. Gerritsen, I. Jolanda M. de Vries, Carl G. Figdor - Clinical Cancer Research 2016 被引用: 374

  9. Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation

    著者: Annelies C. Wauters, Jari F. Scheerstra, Irma G. Vermeijlen, Roel Hammink, Marjolein Schluck, Laura Woythe, Hanglong Wu, Lorenzo Albertazzi, Carl G. Figdor, Jurjen Tel, Loai K. E. A. Abdelmohsen, Jan C. M. van Hest - ACS Nano 2022 被引用: 70

  10. Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

    著者: W. Joost Lesterhuis, Cornelis J.A. Punt, Stanleyson V. Hato, Dagmar Eleveld-Trancikova, Bas Jansen, Stefan Nierkens, Gerty Schreibelt, Annemiek de Boer, Carla M.L. van Herpen, Johannes H.A.M. Kaanders, J. Han van Krieken, Gosse J. Adema, Carl G. Figdor, I. Jolanda M. de Vries - Journal of Clinical Investigation 2011 被引用: 347

  11. Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

    著者: Jurjen Tel, Erik H.J.G. Aarntzen, Tetsuro Baba, Gerty Schreibelt, Barbara M. Schulte, Daniel Benítez‐Ribas, Otto C. Boerman, Sandra Croockewit, Wim J.G. Oyen, Michelle van Rossum, Gregor Winkels, Pierre G. Coulie, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries - Cancer Research 2013 被引用: 342

  12. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

    著者: Paul J. Tacken, I. Jolanda M. de Vries, Ruurd Torensma, Carl G. Figdor - Nature reviews. Immunology 2007 被引用: 738

  13. In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity

    著者: Martijn H. den Brok, Roger P.M. Sutmuller, Robbert van der Voort, Erik Bennink, Carl G. Figdor, Theo J. M. Ruers, Gosse J. Adema - Cancer Research 2004 被引用: 421

  14. Lipid peroxidation causes endosomal antigen release for cross-presentation

    著者: Ilse Dingjan, Daniëlle R. J. Verboogen, Laurent M. Paardekooper, Natalia H. Revelo, Simone P. Sittig, Linda J. Visser, Gabriele Fischer von Mollard, Stefanie Henriet, Carl G. Figdor, Martin ter Beest, Geert van den Bogaart - Scientific Reports 2016 被引用: 155

  15. The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture

    著者: Stefania Di Blasio, Glenn F. van Wigcheren, Anouk M.D. Becker, Anne van Duffelen, Mark A.J. Gorris, Kiek Verrijp, Irene Stefanini, Gert‐Jan Bakker, Martine Bloemendal, Altuna Halilović, Angela Vasaturo, Ghaith Bakdash, Stanleyson V. Hato, Johannes H.W. de Wilt, Joost Schalkwijk, I. Jolanda M. de Vries, Johannes Textor, Ellen H. van den Bogaard, Marcella Tazzari, Carl G. Figdor - Nature Communications 2020 被引用: 87

  16. Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells

    著者: Loek J. Eggermont, Leonie E. Paulis, Jurjen Tel, Carl G. Figdor - Trends in biotechnology 2014 被引用: 222

  17. Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

    著者: Harm Westdorp, Jeroen H. A. Creemers, Inge M. van Oort, Gerty Schreibelt, Mark A.J. Gorris, Niven Mehra, Michiel Simons, Anna L. de Goede, Michelle M. van Rossum, Alexandra Croockewit, Carl G. Figdor, J. Alfred Witjes, Erik H.J.G. Aarntzen, Roel Mus, Mareke Brüning, Katja Petry, Martin Gotthardt, Jelle O. Barentsz, I. Jolanda M. de Vries, Winald R. Gerritsen - Journal for ImmunoTherapy of Cancer 2019 被引用: 113

  18. Targeted Delivery of a Sialic Acid-Blocking Glycomimetic to Cancer Cells Inhibits Metastatic Spread

    著者: Christian Büll, Thomas J. Boltje, Eric A. W. van Dinther, Timo Peters, Annemarie M.A. de Graaf, Jeanette H.W. Leusen, Martin Kreutz, Carl G. Figdor, Martijn H. den Brok, Gosse J. Adema - ACS Nano 2015 被引用: 144

  19. Dendritic cells in cancer immunotherapy

    著者: Camille M. Le Gall, Jorieke Weiden, Loek J. Eggermont, Carl G. Figdor - Nature Materials 2018 被引用: 122

  20. Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and Delivery

    著者: Jorieke Weiden, Dion Voerman, Yusuf Dölen, Rajat Kumar Das, Anne van Duffelen, Roel Hammink, Loek J. Eggermont, Alan E. Rowan, Jurjen Tel, Carl G. Figdor - Frontiers in Immunology 2018 被引用: 83

  21. Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination

    著者: Lieke L. van der Woude, Mark A.J. Gorris, Inge M. N. Wortel, Jeroen H. A. Creemers, Kiek Verrijp, Kim Monkhorst, Katrien Grünberg, Michel M. van den Heuvel, Johannes Textor, Carl G. Figdor, Berber Piet, Willemijn S.M.E. Theelen, I. Jolanda M. de Vries - Journal for ImmunoTherapy of Cancer 2022 被引用: 39

  22. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

    著者: René de Waal Malefyt, John B.A.G. Haanen, Hergen Spits, Maria Grazia Roncarolo, A te Velde, Carl G. Figdor, Keith Johnson, Rob Kastelein, Hans Yssel, J E de Vries - The Journal of Experimental Medicine 1991 被引用: 1,950

  23. Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

    著者: Gerty Schreibelt, Kalijn F. Bol, Harm Westdorp, Florian Wimmers, Erik H.J.G. Aarntzen, Tjitske Duiveman‐de Boer, Mandy W.M.M. van de Rakt, Nicole M. Scharenborg, Annemiek J. de Boer, Jeanette M. Pots, Michel A.M. Olde Nordkamp, Tom G.M. van Oorschot, Jurjen Tel, Gregor Winkels, Katja Petry, Willeke A.M. Blokx, Michelle M. van Rossum, Marieke E.B. Welzen, Roel Mus, Sandra Croockewit, Rutger H.T. Koornstra, Joannes F.M. Jacobs, Sander Kelderman, Christian U. Blank, Winald R. Gerritsen, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries - Clinical Cancer Research 2015 被引用: 235

  24. Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol

    著者: Jeroen H. A. Creemers, Inka Pawlitzky, Konstantina Grosios, Uzi Gileadi, Mark R. Middleton, Winald R. Gerritsen, Niven Mehra, Licia Rivoltini, Ian Walters, Carl G. Figdor, Petronella B. Ottevanger, I. Jolanda M. de Vries - BMJ Open 2021 被引用: 46